D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 46 Citations 5,355 104 World Ranking 10178 National Ranking 27

Research.com Recognitions

Awards & Achievements

2008 - Fellow of the Royal Society of New Zealand

Fellow of the Academy of Social Sciences, United Kingdom

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Organic chemistry
  • Catalysis

Peter C. Tyler mainly focuses on Stereochemistry, Purine nucleoside phosphorylase, Transition state analog, Enzyme and Biochemistry. His research integrates issues of Imine, Transferase, Carbohydrate and Oxocarbenium in his study of Stereochemistry. His studies in Purine nucleoside phosphorylase integrate themes in fields like Guanosine, Reaction coordinate and Nucleophile.

He interconnects Binding site, Hydrogen bond and Hypoxanthine Phosphoribosyltransferase in the investigation of issues within Transition state analog. A large part of his Enzyme studies is devoted to Purine. Peter C. Tyler regularly links together related areas like Nucleotide salvage in his Biochemistry studies.

His most cited work include:

  • One-Third-the-Sites Transition-State Inhibitors for Purine Nucleoside Phosphorylase† (194 citations)
  • Liposomal delivery of antigen to human dendritic cells. (160 citations)
  • Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis (159 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Stereochemistry, Purine nucleoside phosphorylase, Biochemistry, Transition state analog and Enzyme. In his papers, Peter C. Tyler integrates diverse fields, such as Stereochemistry and Transition. His Purine nucleoside phosphorylase study integrates concerns from other disciplines, such as Transferase, Purine metabolism, Inosine, Leaving group and Purine analogue.

His Biochemistry study frequently draws parallels with other fields, such as Nucleotide salvage. The various areas that Peter C. Tyler examines in his Transition state analog study include Hydrolase, Polyamine and Binding site. Enzyme inhibitor is the focus of his Enzyme research.

He most often published in these fields:

  • Stereochemistry (55.70%)
  • Purine nucleoside phosphorylase (27.85%)
  • Biochemistry (27.22%)

What were the highlights of his more recent work (between 2010-2019)?

  • Stereochemistry (55.70%)
  • Biochemistry (27.22%)
  • Enzyme (20.25%)

In recent papers he was focusing on the following fields of study:

Peter C. Tyler mostly deals with Stereochemistry, Biochemistry, Enzyme, Crystal structure and S-adenosylhomocysteine nucleosidase. Peter C. Tyler combines subjects such as Purine nucleoside phosphorylase, Molecule, Entropy and Stereoselectivity with his study of Stereochemistry. His Purine nucleoside phosphorylase research incorporates themes from Methylene, Ribitol and Amine gas treating.

His study in Transition state analog and Active site falls under the purview of Enzyme. Peter C. Tyler has researched Transition state analog in several fields, including Antibiotics and Microbiology. His study looks at the relationship between Hypoxanthine and topics such as Phosphoribosyltransferase, which overlap with Inosine, Hypoxanthine salvage, Purine, Nucleotide salvage and Inosine monophosphate.

Between 2010 and 2019, his most popular works were:

  • Synthesis of a Targeted Library of Heparan Sulfate Hexa- to Dodecasaccharides as Inhibitors of β-Secretase: Potential Therapeutics for Alzheimer’s Disease (59 citations)
  • Acyclic Immucillin Phosphonates: Second-Generation Inhibitors of Plasmodium falciparum Hypoxanthine- Guanine-Xanthine Phosphoribosyltransferase (41 citations)
  • A Picomolar Transition State Analogue Inhibitor of MTAN as a Specific Antibiotic for Helicobacter pylori (32 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Organic chemistry
  • Catalysis

Peter C. Tyler spends much of his time researching Biochemistry, Hypoxanthine, Phosphoribosyltransferase, Stereochemistry and Enzyme. He undertakes interdisciplinary study in the fields of Biochemistry and Chemical synthesis through his works. The Hypoxanthine study combines topics in areas such as Purine nucleoside phosphorylase, Purine, Hypoxanthine salvage and Inosine.

His Phosphoribosyltransferase research includes themes of Inosine monophosphate, Xanthine phosphoribosyltransferase, Nucleotide salvage and Purine metabolism. His research on Stereochemistry focuses in particular on Total synthesis. His Enzyme research includes elements of HEXA, Sulfation, Glycosylation and Function.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

One-Third-the-Sites Transition-State Inhibitors for Purine Nucleoside Phosphorylase†

Robert W. Miles;Peter C. Tyler;Richard H. Furneaux;Carey K. Bagdassarian.
Biochemistry (1998)

313 Citations

Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis

A Fedorov;W Shi;G Kicska;E Fedorov.
Biochemistry (2001)

238 Citations

Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes.

Greg A. Kicska;Li Long;Heidi Hörig;Craig Fairchild.
Proceedings of the National Academy of Sciences of the United States of America (2001)

202 Citations

Liposomal delivery of antigen to human dendritic cells.

Melissa J. Copland;Margaret A. Baird;Thomas Rades;Judith L. McKenzie.
Vaccine (2003)

201 Citations

The 2.0 Å structure of human hypoxanthine-guanine phosphoribosyltransferase in complex with a transition-state analog inhibitor

Wuxian Shi;Caroline M. Li;Peter C. Tyler;Richard H. Furneaux.
Nature Structural & Molecular Biology (1999)

192 Citations

Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase.

Andrzej Lewandowicz;Peter C. Tyler;Gary B. Evans;Richard H. Furneaux.
Journal of Biological Chemistry (2003)

168 Citations

Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function.

Wuxian Shi;Li Min Ting;Gregory A. Kicska;Andrzej Lewandowicz.
Journal of Biological Chemistry (2004)

163 Citations

The 2.0 A structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor.

Wuxian Shi;Caroline M. Li;Peter C. Tyler;Richard H. Furneaux.
Biochemistry (1999)

162 Citations

Femtomolar Transition State Analogue Inhibitors of 5′-Methylthioadenosine/S-Adenosylhomocysteine Nucleosidase from Escherichia coli

Vipender Singh;Gary B. Evans;Dirk H. Lenz;Jennifer M. Mason.
Journal of Biological Chemistry (2005)

162 Citations

Targeting a novel Plasmodium falciparum purine recycling pathway with specific immucillins.

Li Min Ting;Wuxian Shi;Andrzej Lewandowicz;Vipender Singh.
Journal of Biological Chemistry (2005)

136 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter C. Tyler

Vern L. Schramm

Vern L. Schramm

Albert Einstein College of Medicine

Publications: 135

George W. J. Fleet

George W. J. Fleet

University of Oxford

Publications: 32

Luke W. Guddat

Luke W. Guddat

University of Queensland

Publications: 29

David Shugar

David Shugar

Polish Academy of Sciences

Publications: 19

Richard H. Furneaux

Richard H. Furneaux

Victoria University of Wellington

Publications: 17

Lieve Naesens

Lieve Naesens

Rega Institute for Medical Research

Publications: 17

Walter Filgueira de Azevedo

Walter Filgueira de Azevedo

Pontifical Catholic University of Rio Grande do Sul

Publications: 15

Adrian S. Ray

Adrian S. Ray

Yale University

Publications: 12

Jan Steyaert

Jan Steyaert

Vrije Universiteit Brussel

Publications: 12

Thomas Rades

Thomas Rades

University of Copenhagen

Publications: 12

Kami Kim

Kami Kim

University of South Florida

Publications: 10

Steven C. Almo

Steven C. Almo

Albert Einstein College of Medicine

Publications: 9

Istvan Toth

Istvan Toth

University of Queensland

Publications: 9

Terry D. Butters

Terry D. Butters

University of Oxford

Publications: 9

Steven E. Ealick

Steven E. Ealick

Cornell University

Publications: 8

Gideon J. Davies

Gideon J. Davies

University of York

Publications: 8

Trending Scientists

Yueting Zhuang

Yueting Zhuang

Zhejiang University

Shinji Nishiwaki

Shinji Nishiwaki

Kyoto University

Rami Haj-Ali

Rami Haj-Ali

Tel Aviv University

Imre G. Csizmadia

Imre G. Csizmadia

University of Toronto

Masilamani Jeganmohan

Masilamani Jeganmohan

Indian Institute of Technology Madras

William Clegg

William Clegg

Newcastle University

Edi Syams Zainudin

Edi Syams Zainudin

Universiti Putra Malaysia

William G. Hill

William G. Hill

University of Edinburgh

Ann Bucklin

Ann Bucklin

University of Connecticut

Wan-Uk Kim

Wan-Uk Kim

Catholic University of Korea

Marco L. Fiorentini

Marco L. Fiorentini

University of Western Australia

Norman R. Warpinski

Norman R. Warpinski

Halliburton (United Kingdom)

Aize Kijlstra

Aize Kijlstra

Maastricht University

Zoltán Prohászka

Zoltán Prohászka

Semmelweis University

Mary Anne Fitzpatrick

Mary Anne Fitzpatrick

University of Wisconsin–Madison

Robert W. Thompson

Robert W. Thompson

Washington University in St. Louis

Something went wrong. Please try again later.